Moloney Securities Asset Management LLC Makes New $559,000 Investment in Grail, Inc. (NASDAQ:GRAL)

Moloney Securities Asset Management LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 31,336 shares of the company’s stock, valued at approximately $559,000. Moloney Securities Asset Management LLC owned approximately 0.09% of Grail at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Wilmington Savings Fund Society FSB bought a new position in shares of Grail in the 4th quarter valued at approximately $64,000. abrdn plc acquired a new position in Grail during the fourth quarter valued at approximately $3,768,000. China Universal Asset Management Co. Ltd. bought a new position in shares of Grail in the fourth quarter valued at approximately $127,000. Perigon Wealth Management LLC acquired a new stake in shares of Grail in the fourth quarter worth $260,000. Finally, Slow Capital Inc. bought a new stake in shares of Grail during the 4th quarter worth $2,379,000.

Grail Price Performance

Shares of Grail stock opened at $33.37 on Tuesday. The firm has a fifty day moving average price of $21.72 and a two-hundred day moving average price of $17.18. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $35.67.

Grail (NASDAQ:GRAL) last released its earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The company had revenue of $28.65 million during the quarter. As a group, analysts expect that Grail, Inc. will post -65.16 EPS for the current fiscal year.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Guggenheim initiated coverage on shares of Grail in a report on Thursday, October 17th. They issued a “neutral” rating on the stock. Wolfe Research started coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating for the company. Finally, Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price for the company.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.